ALLIANCEBERNSTEIN L.P. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$18,552,000
+1557.9%
492,486
+648.5%
0.01%
+700.0%
Q4 2020$1,119,000
+217.0%
65,800
-12.4%
0.00%
Q3 2020$353,000
-22.9%
75,1000.0%0.00%
Q2 2020$458,000
+218.1%
75,100
+18.1%
0.00%
Q1 2020$144,000
-47.6%
63,600
+6.2%
0.00%
Q4 2019$275,000
+17.5%
59,900
-0.8%
0.00%
Q3 2019$234,000
-35.7%
60,4000.0%0.00%
Q2 2019$364,000
-45.6%
60,400
+21.0%
0.00%
Q1 2019$669,000
-65.0%
49,900
-75.8%
0.00%
-100.0%
Q4 2018$1,914,000
+175.4%
205,800
+312.4%
0.00%
Q3 2018$695,000
-11.9%
49,9000.0%0.00%
-100.0%
Q2 2018$789,000
-2.4%
49,900
+6.1%
0.00%0.0%
Q1 2018$808,000
-20.2%
47,020
+1.8%
0.00%0.0%
Q4 2017$1,013,000
-46.4%
46,2000.0%0.00%0.0%
Q3 2017$1,890,000
+35.9%
46,2000.0%0.00%0.0%
Q2 2017$1,391,000
-60.6%
46,200
-52.7%
0.00%
-66.7%
Q1 2017$3,534,000
-21.2%
97,770
+9.2%
0.00%
-25.0%
Q4 2016$4,487,000
-20.7%
89,550
-16.9%
0.00%
-20.0%
Q3 2016$5,656,000
+63.8%
107,750
+29.0%
0.01%
+66.7%
Q2 2016$3,453,000
+144.7%
83,500
+140.4%
0.00%
+200.0%
Q1 2016$1,411,000
+24.1%
34,740
+26.8%
0.00%0.0%
Q4 2015$1,137,000
+293.4%
27,400
+45.7%
0.00%
Q3 2015$289,000
-24.9%
18,800
+21.3%
0.00%
Q2 2015$385,000
+110.4%
15,500
+93.8%
0.00%
Q1 2015$183,000
+471.9%
8,000
+566.7%
0.00%
Q4 2014$32,000
+128.6%
1,2000.0%0.00%
Q3 2014$14,000
-62.2%
1,200
-50.0%
0.00%
Q2 2014$37,0002,4000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 3,381,117$47,065,0004.14%
GREAT POINT PARTNERS LLC 1,647,753$22,937,0003.58%
Rock Springs Capital Management LP 598,000$8,324,0000.30%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 136,029$1,894,0000.14%
FOX RUN MANAGEMENT, L.L.C. 20,935$291,0000.13%
Hilltop Holdings Inc. 39,824$554,0000.12%
WEXFORD CAPITAL LP 112,700$1,569,0000.10%
OXFORD ASSET MANAGEMENT LLP 296,339$4,132,0000.09%
Vident Investment Advisory, LLC 133,272$1,855,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 90,000$1,253,0000.06%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders